Macías Parra Mercedes, Kumate Rodríguez Jesús, Arredondo García José Luís, López-Vidal Yolanda, Castañón-Arreola Mauricio, Balandrano Susana, Rastogi Nalin, Gutiérrez Castrellón Pedro
Department of Infectious Diseases, Instituto Nacional de Pediatría, Mexico City, Mexico.
Tuberc Res Treat. 2011;2011:239042. doi: 10.1155/2011/239042. Epub 2011 Aug 23.
The aim of this study was to determine the frequency of drug resistance and the clonality of genotype patterns in M. tuberculosis clinical isolates from pediatric patients in Mexico (n = 90 patients from 19 states; time period-January 2002 to December 2003). Pulmonary disease was the most frequent clinical manifestation (71%). Children with systemic tuberculosis (TB) were significantly younger compared to patients with localized TB infections (mean 7.7 ± 6.2 years versus 15 ± 3.4 years P = 0.001). Resistance to any anti-TB drug was detected in 24/90 (26.7%) of the isolates; 21/90 (23.3%) and 10/90 (11.1%) were resistant to Isoniazid and Rifampicin, respectively, and 10/90 (11.1%) strains were multidrug-resistant (MDR). Spoligotyping produced a total of 55 different patterns; 12/55 corresponded to clustered isolates (n = 47, clustering rate of 52.2%), and 43/55 to unclustered isolates (19 patterns were designated as orphan by the SITVIT2 database). Database comparison led to designation of 36 shared types (SITs); 32 SITs (n = 65 isolates) matched a preexisting shared type in SITVIT2, whereas 4 SITs (n = 6 isolates) were newly created. Lineage classification based on principal genetic groups (PGG) revealed that 10% of the strains belonged to PGG1 (Bovis and Manu lineages). Among PGG2/3 group, the most predominant clade was the Latin-American and Mediterranean (LAM) in 27.8% of isolates, followed by Haarlem and T lineages. The number of single drug-resistant (DR) and multidrug-resistant (MDR-TB) isolates in this study was similar to previously reported in studies from adult population with risk factors. No association between the spoligotype, age, region, or resistance pattern was observed. However, contrary to a study on M. tuberculosis spoligotyping in Acapulco city that characterized a single cluster of SIT19 corresponding to the EAI2-Manila lineage in 70 (26%) of patients, not a single SIT19 isolate was found in our pediatric patient population. Neither did we find any shared type belonging to the EAI family which represents ancestral PGG1 strains within the M. tuberculosis complex. We conclude that the population structure of pediatric TB in our setting is different from the one prevailing in adult TB patient population of Guerrero.
本研究的目的是确定墨西哥儿科患者结核分枝杆菌临床分离株(来自19个州的90名患者;时间段为2002年1月至2003年12月)的耐药频率和基因型模式的克隆性。肺部疾病是最常见的临床表现(71%)。与局限性结核感染患者相比,全身性结核病患儿明显更年幼(平均7.7±6.2岁对15±3.4岁,P = 0.001)。在90株分离株中的24株(26.7%)检测到对任何抗结核药物耐药;90株中的21株(23.3%)和90株中的10株(11.1%)分别对异烟肼和利福平耐药,10株(11.1%)菌株为耐多药(MDR)。间隔寡核苷酸分型产生了总共55种不同模式;55种中的12种对应聚集性分离株(n = 47,聚集率为52.2%),55种中的43种对应非聚集性分离株(19种模式被SITVIT2数据库指定为孤儿型)。数据库比较导致指定了36种共享类型(SITs);32种SITs(n = 65株分离株)与SITVIT2中预先存在的共享类型匹配,而4种SITs(n = 6株分离株)是新创建的。基于主要遗传群(PGG)的谱系分类显示,10%的菌株属于PGG1(牛型和人型谱系)。在PGG2/3组中,最主要的进化枝是拉丁美洲和地中海型(LAM),占分离株的27.8%,其次是哈勒姆型和T型谱系。本研究中单耐药(DR)和耐多药(MDR-TB)分离株的数量与先前报道的有危险因素的成年人群研究相似。未观察到间隔寡核苷酸分型、年龄、地区或耐药模式之间的关联。然而,与在阿卡普尔科市进行的一项关于结核分枝杆菌间隔寡核苷酸分型的研究相反,该研究在70名(26%)患者中鉴定出对应于EAI2-马尼拉谱系的单个SIT19簇,而在我们的儿科患者群体中未发现单个SIT19分离株。我们也未发现任何属于EAI家族的共享类型,该家族代表结核分枝杆菌复合体内的祖先PGG1菌株。我们得出结论,我们研究环境中儿科结核病的人群结构与格雷罗州成年结核病患者群体中普遍存在的结构不同。